BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.000
+0.005 (0.25%)
At close: Jul 10, 2025, 4:00 PM
2.100
+0.100 (5.00%)
After-hours: Jul 10, 2025, 7:56 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $12.11 million as of July 10, 2025. Its market cap has decreased by -72.88% in one year.

Market Cap
12.11M
Enterprise Value
86.98M
1-Year Change
-72.88%
Ranking
Category
Stock Price
$2.00

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $12.11M, a decrease of -92.98%. That is a compound annual growth rate of -30.35%.

History

DateMarket Cap% Change
Jul 10, 202512.11M-34.73%
Dec 31, 202418.56M-78.51%
Dec 29, 202386.35M-85.65%
Dec 30, 2022601.94M5.82%
Dec 31, 2021568.84M-49.47%
Dec 31, 20201.13B327.27%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 706.50B
Johnson & Johnson 374.02B
AbbVie 334.70B
Novo Nordisk 308.12B
UnitedHealth Group 277.49B
Novartis AG 240.05B
Abbott Laboratories 232.25B
AstraZeneca 216.19B
Market Cap Rankings